Inhibikase Therapeutics, Inc. - Common Stock (NQ:IKT)
2.010
-0.020
(-0.99%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 16, 2025
Add to My Watchlist
Headline News about Inhibikase Therapeutics, Inc. - Common Stock



Earnings Preview: Inhibikase Therapeutics
May 12, 2023
Via Benzinga


Looking Into Inhibikase Therapeutics's Return On Capital Employed
December 27, 2022
Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session
September 19, 2023
Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session
August 25, 2023
Via Benzinga




Via Benzinga










Benzinga's Top Ratings Upgrades, Downgrades For November 16, 2022
November 16, 2022
Via Benzinga








Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.